Hernández-Rojas, Myriam L <br/><br/>
Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.  [electronic resource] 

 -  Retina (Philadelphia, Pa.)   
 - 707-12 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0275-004X 
<br/><br/><label>Standard No.: </label>10.1097/GIM.0b013e3180a03276  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Choroidal Neovascularization--diagnosis<br/>Female<br/>Fluorescein Angiography<br/>Follow-Up Studies<br/>Fovea Centralis<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Myopia, Degenerative--complications<br/>Prospective Studies<br/>Retina--drug effects<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--drug effects<br/>Vitreous Body